
GemPharmatech
GemPharmatech is a biotechnology firm that focuses on the generation and distribution of genome-modified mouse and immune-checkpoint models. Read more
GemPharmatech is a biotechnology firm that focuses on the generation and distribution of genome-modified mouse and immune-checkpoint models. Read more
GemPharmatech is a biotechnology firm that focuses on the generation and distribution of genome-modified mouse and immune-checkpoint models. Read more
President
Xiang Gao
Taconic Biosciences, Inc. is one of GemPharmatech's top rivals. Taconic Biosciences, Inc. was founded in Rensselaer, New York} in 1952. Like GemPharmatech, Taconic Biosciences, Inc. also competes in the Medical Research & Laboratories space. Compared to GemPharmatech, Taconic Biosciences, Inc. generates $225M more revenue.
No recent acquisitions found related to GemPharmatech
Since GemPharmatech was founded in 2017, it has participated in 2 rounds of funding. In total GemPharmatech has raised $81.7M. GemPharmatech's last funding round was on Sep 2020 for a total of $58.5M
No recent investments found related to GemPharmatech